Diabetes, Drugs and Dangerous Discrepancies. Sally Bodenhamer, OD, OT/L, CDE

Similar documents
Diabetes Oral Agents Pharmacology. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

What s New in Diabetes Treatment. Disclosures

Oral Medication for the Management of Diabetes Mechanism of. Duration of Daily Dosing Action

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

RPCC Pharmacy Forum. The Type 2 Diabetes Issue. Type 2 Diabetes: The Basics

DM Fundamentals Class 4 Meds for Type 2

DM Fundamentals Class 4 Meds for Type 2

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Type II Diabetes Improving Blood Sugar Control. Geneva Clark Briggs, Pharm.D., BCPS

4/9/2018 HOW TO REGULATE DIABETES MEDICATIONS. By Sarah Froemsdorf MSN, RNC, CDE, FNP DISCLOSURES NONE. Diagnosis

Diabetes: Just the Basics

Chief of Endocrinology East Orange General Hospital

Oral and Injectable Non-insulin Antihyperglycemic Agents

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Diabetes Medication Updates Erica Bukovich, PharmD, BC-ADM, CDE September 20, 2018

What s New in Diabetes Medications. Jena Torpin, PharmD

Metabolic Syndrome: What s so big about BIG?

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Diabetes School October 2016

DIABETES. overview of pharmacologic agents used in the management of. Overview 4/3/2014 OBJECTIVES. Injectable Agents

Diabetes Medications: Oral Anti-Hyperglycemic Medications

Diabetes Management: A diagnostic perspective

Diabetes Mellitus Type 2

Choosing a Diabetes Strategy Where to Start and Where to Go

Age-adjusted Percentage of U.S. Adults Who Were Obese or Who Had Diagnosed Diabetes

Wayne Gravois, MD August 6, 2017

Joslin Diabetes Center Joslin Diabetes Forum 2013: The Impact of Comorbidities on Glucose Control Scenario 2: Reduced Renal Function

Diabetes Basics - The who, what, why, and how of diabetes care

Endo 2 SLO Practice (online) Page 1 of 7

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

The information in this guide comes from a government-funded review of research about pills for type 2 diabetes.

ABOUT TYPE 2 DIABETES

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Treatment Options for Diabetes: An Update

What s New on the Horizon: Diabetes Medication Update

YOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013

Multiple Small Feedings of the Mind: Diabetes. Sonja K Fredrickson, MD, BC-ADM March 7, 2014

Management of Type 2 Diabetes. Why Do We Bother to Achieve Good Control in DM2. Insulin Secretion. The Importance of BP and Glucose Control

Rebecca Newberry APRN MS CDE

What s New on the Horizon: Diabetes Medication Update. Michael Shannon, MD Providence Endocrinology, Olympia WA

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Copyright 2003 How long does it take metformin to lower blood sugar. All rights reserved.

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Glucose Control drug treatments

Newer Drugs in the Management of Type 2 Diabetes Mellitus

I. General Considerations

Update on Diabetes Mellitus

Multiple Factors Should Be Considered When Setting a Glycemic Goal

Non-Insulin Diabetes Medications Summary

The Death of Sulfonylureas? A Review of New Diabetes Medications

Diabetes: Assessing your risk

Get Healthy Stay Healthy

Jonathan Stoehr, MD PhD Endocrinology, Diabetes, Metabolism and Nutrition Virginia Mason Medical Center Seattle, WA 2012 Virginia Mason Medical

New Treatments for Type 2 diabetes. Nandini Seevaratnam April 2016 Rushcliffe Patient Forum

Quick Guide MEDICATIONS 7th Edition Evan Sisson, Pharm.D., MHA, CDE

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

Disclosure. Learning Objectives. Case. Diabetes Update: Incretin Agents in Diabetes-When to Use Them? I have no disclosures to declare

Diabetes update - Diagnosis and Treatment

Pharmacologic Agents for Treatment of Type 2 Diabetes

Modulating the Incretin System: A New Therapeutic Strategy for Type 2 Diabetes. Overview. Prevalence of Overweight in the U.S.

Jeffery Davies, DO, MPH, FACOEP ACOEP Chicago, IL October Your DM patient is ready for discharge, now what?

The Many Faces of T2DM in Long-term Care Facilities

Table 1. Antihyperglycemic agents for use in type 2 diabetes

How can we improve outcomes in Type 2 diabetes?

Oral and Injectable Medication Options for Diabetes Treatment

Helpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center

Newer and Expensive treatment of diabetes. Endocrinology Visiting Associate Professor Institute of Medicine TUTH

GLP-1 (glucagon-like peptide-1) Agonists (Byetta, Bydureon, Tanzeum, Trulicity, Victoza ) Step Therapy and Quantity Limit Criteria Program Summary

How they work and when to take them. Diabetes Medications

Side Effects of: GLP-1 agonists DPP-4 inhibitors SGLT-2 inhibitors. Bryce Fukunaga PharmD April 25, 2018

Individualizing Care for Patients with Type 2 Diabetes

Living with Diabetes

Rhonda Eustice, PharmD, CDE. Will Power lasts about two weeks and is soluble in alcohol. Mark Twain

Changing Diabetes: The time is now!

Advanced Practice Education Associates. Endocrine

Insulin Initiation and Intensification. Disclosure. Objectives

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

Diabetes Mellitus II CPG

FUNDING: MICIS mandated by Maine Legislature, funded by fees collected from pharmaceutical companies as a cost of doing business in the state.

Learning Objectives. Impact of Diabetes II UPDATES IN TYPE 2 DIABETES. David Doriguzzi, PA-C

Antihyperglycemic Agents in Diabetes. Jamie Messenger, PharmD, CPP Department of Family Medicine East Carolina University August 18, 2014

Chapter 24 Diabetes Mellitus

A New Therapeutic Strategey for Type II Diabetes: Update 2008

Clinical Practice Guidelines

Type 2 Diabetes Mellitus hypoglycaemic agents

Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Insulins. Rapid Short Intermediate Long Mix

Type 2 Diabetes Mellitus 2011

OBJECTIVES 4/7/2014. Diabetes Update Overview of the Diabetes Epidemic in the United States. ISHP Annual Spring Meeting

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

Individualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD

Joshua Settle, PharmD Clinical Pharmacist Baptist Medical Center South ALSHP Fall Meeting September 30, 2016

第十五章. Diabetes Mellitus

Sect S io ecn ti 1 o : n Trend 1: Tres nds

Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes

Nurse practitioners on the front lines of diabetes diagnosis and management

Pharmacology Updates. Quang T Nguyen, FACP, FACE, FTOS 11/18/17

Transcription:

Diabetes, Drugs and Dangerous Discrepancies Sally Bodenhamer, OD, OT/L, CDE

I have no disclosures Disclosures

$245 BILLION American DM ASSOC 2012 cost of Diabetes Economic Costs of Diabetes in the U.S. in 2012 $245 billion, including $176 billion in direct medical costs and $69 billion in reduced productivity.

Every Single Day in the U.S. 5,205 new cases of diabetes are diagnosed 230 people have diabetes-related amputations 133 people progress to End Stage Renal Disease 55 people with Diabetes become BLIND Centers for Disease Control and Prevention 2011National Diabetes Fact Sheets

Genes predispose us to Diabetes and OR obesity but we pull the trigger with our environment

Goals when you leave my office Stop smoking! Number one risk factor for amputation Stop drinking sweet TASTING beverages ( I don t care if it is diet!) No fruit juice no soda, no artificially sweetened water Know your NUMBERS : A1C, Fasting, Post-prandial, LDL, Triglycerides, HDL Know Diabetes affects EVERYTHING! (arthritis, pancreatitis, carpaltunnel)

I just have Pre-Diabetes Fasting Glucose: 100mg/dl 125mg/dl A1C: 5.7% 6.4% Glucose Tolerance: 140mg/dl 199mg/dl Reference: www.diabetes.org

Diagnosing Diabetes Random glucose 200mg/dL Fasting glucose 126 mg/dl A1C 6.5% These require repeat testing A1C should not be used for Type 1 or Gestational and may be misleading in hemaglobinopathies (anemias, thalassemias etc) *American Diabetes Asociation. Diabetes Care 2013 Jan; (suppl 1): s11-66

We Are Important! Diabetic Retinopathy is the leading cause of blindness in U.S. adults >50 years old The fear of blindness exceeds many patients fear of death The American Association of Clinical Endocrinologist recommends any person with ANY retinopathy have a dilated retinal exam at least every 6 months Primary care doctors will hear we are talking to our patients and they WANT OUR HELP (and dilation reports)

Why is it so Complicated??

Most important thing to discuss with our captive patients Reference: www.lillydiabetes.com

Discuss Dietary and Medication Compliance

A1c Targets

Medication Options Biguanides GLP-1 RA Sulfonylureas Meglitinides Thiazolidinediones DPP-4 inhibitors SGLT2 Inhibitors Alpha-glucosidase inhibitors Bromocriptine

Why is it so Complicated?

Biguanides (Muscle & Liver) METFORMIN (Glucophage) Slows glucose release from the liver Affects FASTING glucose Is weight NEUTRAL Interacts with Tagamet (Tagamet prevents excretion and can increase amount of metformin in system by 40%) Contraindicated in severe renal and liver impairment; rare S.E. lactic acidosis 1:30,000

What the heck is GLP-1? (Brain & Small Intestines) INJECTABLE Glucagon like peptide (incretin) Secreted by cells in the intestinal wall Delays gastric emptying, decreases glucagon from the liver, prevents Beta apoptosis Stimulates the release of insulin

Incretin mimetics: Byetta, Victoza, Bydureon Glucagon-Like Peptide Receptor Analogs Target Incretin ( incretin mimetic)- people with DM are low on this hormone Injectable: b.i.d, q daily, q weekly Assists with weight loss, does not cause hypoglycemia, contraindicated with pancreatitis, controversy on pancreatic cancer studies S.E. nausea-dissipates with time

DPP4 Inhibitors: gliptins Onglyza, Januvia DPP4 breaks down GLP-1 (half life 2 min) Oral Weight neutral, act only on demand Controversial in patients with previous pancreatitis or thyroid issues May be safer in older adults because of less effect on appetite

Alpha Glucosidase Inhibitors: acarbose, miglitol (Intestines) Slow down the digestion of complex carbs like bread and pasta Do NOT affect simple sugars like milk or fruit GI disturbances and be helped by tapering medication up Weight NEUTRAL, will not cause hypoglycemia on it s own If low occurs due to other medications, do not use Soda to try to bring sugar back up Take with first bite of food

Are you ready to go on the Donkey Diet yet?

Why is it so Complicated?

SGLT-2 Inhibitors: the FLOzins (Kidneys) Sodium Glucose co-transporter-protein that reabsorbs glucose in the kidney Doc, I have a new medicine to pee out my sugar Helps with weight loss Vaginal yeast infection and UTI

Bromocriptine what the heck? (Brain) Ergot alkaloid-mycotoxin from fungus Helps with abnormal milk discharge (think pituitary problems), infertility, Parkinson s Affects circadian rhythms in the hypothalamus driving cravings for sugar and high triglyceride foods Weight neutral and only has MILD GI side effects

Sulfonylureas: glipizide, Glyburide (Pancreas) Becoming a last resort Increase Insulin release from the Beta Cells Cause weight GAIN Cause moderate to severe HYPOGLYCEMIA Aspirin can make hypoglycemia worse Contraindicated in renal insufficiency and severe liver disease

Thioglitazones: Actos, Avandia (Liver) Reduce insulin resistance in the liver and peripheral tissues Reduces the amount of glucose withdrawn from the liver FASTING Can cause bone fractures in hands and feet (moderate bone loss) Causes fluid retention (macular edema, worsening of CHF, respiratory infection) Weight gain (fluid retention) Bladder cancer studies have not supported causal relationship

Meglitinides: Prandin, Starlix, Glufast (Pancreas) Act on the beta cells Increases insulin therefore causes weight gain and potentiates hypoglycemia Rat studies have shown increase in benign tumors of thyroid and liver

Switching Gears Post-prandial glucose is and IDEPENDENT risk factor for mortality DECODE study followed 25,000 people for a little over 7 years found increased mortality risk was much more closely associated with 2-h post glucose load than with fasting glucose More recent studies have demonstrated that even moderate postprandial hyperglycemia (148 199 mg/dl) is not only more indicative of atherosclerosis than is fasting glucose, but also may have direct adverse effects on the endothelium. DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 354:617 621,1999 Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T: Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals.atherosclerosis 144:229 235,1999

Discuss Dangers of Hypoglycemia Is it really hypoglycemia (less than 70mg/dL)? Loss of hypoglycemia awareness with repeated episodes Appropriate ways to address lows Dead In Bed Syndrome

Discuss Side Effects Nausea is NOT not finishing your plate GI disturbances contributed to by sick gut/ unhealthy diet (diarrhea) Need to incorporate more whole, raw foods

Why is this important to EVERYONE in this room? A 23 year-old patient with type 1 diabetes visits her endocrinologist every three months. Which of the following in the most appropriate recommendation for this patient to maintain healthy vision? A. The endocrinologist should visually inspect the patient s eyes at each visit. B. An ophthalmologist should perform a dilated eye exam annually. C. An optometrist should evaluate the patient for corrective lenses every three years. D. The endocrinologist should physically examine the patient s eyes twice yearly

A 41 year-old man with recently diagnosed type-2 diabetes presents for diabetes education. He complains of blurry vision and states that he cannot read the newspaper print. He does not wear corrective lenses and his last eye exam was five years ago. What is the most appropriate recommendation? A. Referral to an Optometrist for a vision screening. B. Referral to an Ophthalmologist for a comprehensive dilated eye exam. C. Purchase reading glasses. D. Wait three months to see if vision improves.

Thank You!